Expert Interview: Pfizer/BioNTech Immune Response in Pediatric Clinical Trials
Pfizer/BioNTech announce positive results for a third dose of their COVID-19 vaccine for children.
Grant Paulsen, MD, assistant professor, Division of Infectious Disease, Department of Pediatrics, Cincinnati Children's Hospital Medical Center in Ohio, and primary investigator for the hospital's clinical trial for a third dose (booster) for the Pfizer/BioNTech vaccine for COVID-19, discusses what the data might mean for children aged 5 to 11 years.
This article originally appaered on Contemporary Pediatrics.
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Recent Videos
Related Content
